Keywords:
adenosine receptor
caffeine consumption
cognition
dose
hypothalamus
neurodegenerative diseases
pharmacodynamic

  • Abstract

    This review aims to analyze and contrast the neurological effects associated with the use of caffeine on neurobehavior and neuroprotection in animal models. Caffeine belongs to the group of methylxanthines that exert a direct effect on adenosine receptors associated with inhibitory or excitatory G proteins, generating modification of cyclic AMP activity and intracellular calcium flow which produces alterations in the modulation system of the neurotransmitters dopamine and glutamate. The regulation of the neurotransmission systems generates protection against the inflammation of the central nervous system, by activation of the microglia and reinforcement of the blood-brain barrier. This drug will also restore cognition or prevent memory loss in Parkinson's or Alzheimer's diseases. It is important to establish new study models in other species to assess whether the behavior of the molecule is similar and to obtain other clinical applications in its behavioral and neuroprotective effects.

  • References

    1. Abu- Sa’da OS, Armstrong EA, Scott O, Shaw O, Nguyen AT, Shen K, Cheung P, Baker G, Yager JY (2018) The effect of caffeine on the neuropathological and neurobehavioral outcome in the newborn rat. Journal of Caffeine and Adenosine Research 8:143-152.
    2. Alasmari F (2020) Caffeine induces neurobehavioral effects through modulating neurotransmitters. Saudi Pharmaceutical Journal 28:445-451.
    3. American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders, 5th edition, Washinton, DC: American Psychiatric Press.
    4. Angelucci MEM, Cesário C, Hiroi RH, Rosalen PL, Cunha D (2002) Effects of caffeine in learning and memory in rats tested in the Morris water maze. Bazilian Journal of Medical and Biological Research 35:1201-1208.
    5. Assis MS, Soares AC, Sousa DN, Eudes- Filho J, Faro LR, Carneiro FP, Silva MV, Motoyama AB, Souza GM, Marchiori S, Lima NT, Boëchat- Barros R, Ferreira VM (2018) Effects of Caffeine on Behavioral and Cognitive Deficits in Rats. Basic & Clinical Pharmacology & Toxicology 123:435-442.
    6. Avegno EM, Gilpin NW (2019) Inducing alcohol dependence in rats using chronic intermittent exposure to alcohol vapor. Bio- Protocol 9:e3222.
    7. Barcelos RP, Souza MA, Amaral GP, Stefanello ST, Bresciani G, Fighera MR, Soares FAA, Barbosa NV (2014) Caffeine supplementation modulates oxidative stress markers in the liver of trained rats. Life Sciences 96:40-5.
    8. Bassett L, Troncy E, Pouliot M, Paquette D, Ascah A, Authier S (2014) Telemetry video- electroencephalography (EEG) in rats, dogs and dogs and non- human primates: Methods in follow- up safety pharmacology seizure liability assessments. Journal of Pharmacological and Toxicological Methods 70:230-240.
    9. Bhattacharya SK, Satyan KS, Chakrabarti A (1997) Anxiogenic action of caffeine: an Experimental study in rats Journal of Psychopharmacology 11:219-224.
    10. Brothers HM, Marchalant Y, Wenk GL (2010) Caffeine attenuates lipopolysaccharide- induced neuroinflammation. Neurosciences Letters 480:97-100.
    11. Burke LM, (2008) Caffeine and Sports Performance. Applied Physiology, Nutrition and Metabolism 33:1319-34.
    12. Buscariollo DL, Breuer GA, Wendler CC, Rivkees SS, (2011) Caffeine acts via A1 adenosine receptors to disrupt embryonic cardiac function. PLoS One 6:e28296.
    13. Buscariollo DL, Fang X, Greenwood V, Xue, H, Rivkees SA, Wendler CC (2014) Embryonic caffeine exposure acts via A1 adenosine receptors to alter adult cardiac function and DNA methylation in mice. PLoS One 9:e87547.
    14. Cappelletti S, Daria P, Sani G, Aromatario M (2015) Caffeine: Cognitive and Physical Performance Enhancer or Psychoacyive Drug? Current Neuropharmacology 13:71-88.
    15. Charney DS, Heninger GR, Jatlow PI (1985) Increased Anxiogenic Effects of Caffeine in Panic Disorders. Archives of General Psychiatry 42:233-243.
    16. Chen X, Ghribi O, Geiger JD (2010) Caffeine Protects Against Disruptions of the Blood- Brain Barrier in Animals Models of Alzheimer´s and Parkinson´s Diseases. Journal of Alzheimer´s Disease 20:S127-S141.
    17. Cognato GP, Agostinho PM, Hockemeyer J, Müller CE, Souza DO, Cunha RA (2010) Caffeine and an adenosine A(2A) receptor antagonist prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life, Journal of Neurochemistry 112:453-462.
    18. Colella M, Zinni M, Pansiot J, Cassanello M, Mairesse J, Ramenghi L, Baud O (2018) Modulation of Microglial Activation by Adenosine A2a Receptor in Animal Models of Perinatal Brain Injury. Frontiers in Neurology 9:605.
    19. Corsi C, Melani A, Bianchi L, Pedata F (2000) Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats. Neuroreport 11:2591-5.
    20. Dai SS, Zhou HY, Li W, An JH, Li P, Yang N, Chen XY, Xiong RP, Liu P, Zhao Y, Shen HY, Zhu PF, Chen JF (2010) Local glutamate levels distaste adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury. Journal of Neuroscience 30:5602-5010.
    21. Das SC, Yamamoto BK, Hristov AM, Sari Y (2015) Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats. Neuropharmacology 97:67-74.
    22. De Freitas AP, Ferreira DDP, Fernandes A, Martins RS, Borges- Martins VPP, Sthaler MF, Dos- Santos- Pereira M, Paes- de Carvalho R, Giestal- de- Araujo E, de Melo Reis RA, Kubrusly RC (2016) Caffeine Alters Glutamate- Aspartate Transposter Function and Expression in Rat Retina. Neuroscience 19:285-294
    23. Dewey CW, Davies E, Xie H, Wakshlag JJ (2019) Canine Cognitive Dysfunction: Pathophysiology, Diagnosis, and Treatment. Veterinary Clinics of North America: Small Animal Practice 49:477- 499.
    24. Di Martino E, Bocchetta E, Tsuji S, Mukai T, Harris RA, Blomgren K, Ådén U (2020) Defining a Time Window for Neuroprotection and Glia Modulation by Caffeine After Neonatal Hypoxia-Ischaemia. Molecular Neurobiology 57:2194-2205.
    25. Dias RB, Rombo DM, Ribeiro JA, Henley JM, Sebastiäo AM (2013) Adenosine: setting the stage for plasticity. Trends in Neurosciences 3:248-257.
    26. Diler A, Ziya Y, Üzüm G (2013) N- methyl- D- aspartate Receptors Are involved in Caffeine- Induced Facilitation on Memory Retention of Passive Avoidance Learning in Rats, Journal of Caffeine Research 3:169-174.
    27. Edwards S, Vendruscolo LF, Schlosburg JE, Misra KK, Wee S, Park PE, Schulteis G, Koob GF (2012) Development of mechanical hypersensitivity in rats during heroin and ethanol dependence: alleviation by CRF(1) receptor antagonism. Neuropharmacology 62:1142-1151.
    28. El Yacoubi M, Ledent C, Parmentier M, Costentin J, Vaugeois JM (2000) The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists. Journal of Psychopharmacology 148:153-63.
    29. Ferré S, von Euler G, Johansson B, Fredholm BB, Fuxe K (1991) Stimulation of high- affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proceedings of the National Academy of Sciences the United States of America 88:7138-7241.
    30. Ferreira DDP, Stutz B, de Mello FG, Reis RAM, Kubrusly RCC (2014) Caffeine Potentiates the Release of GABA Meidated by NMDA Receptor Activation: Involvement of A1 Adenosine Receptors. Neuroscience 281:208-215.
    31. Fisone G, Borgkvist A, Usiello A (2004) Caffeine as a psychomotor stimulant: mechanism of action. Cellular and Molecular Life Sciences 61:857-72.
    32. Franca AP, Takahashi RN, Cunha RA, Prediger RD (2018) Promises of Caffeine in Attention- Deficit/ Hyperactivity Disorder: From Animal Models to Clinical Practice. Journal of Caffeine and Adenosine Research 8:131-142.
    33. Fredholm BB, AP IJ, Jacobson KA, Linden J, Muller CE (2011) International Union of Basic and Clinical Pharmacology. LXXXI Nomenclature and classification of adenosine receptors--an update. Pharmacological Reviews 63:1-34.
    34. Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacological Reviews 51:83-133.
    35. Fredholm BB, Chen JF, Cunha RA, Svenningsson P, Vaugeosis JM (2005) Adenosine and brain function. International Review of Neurobiology 63:191-270.
    36. Fredholm BB, Hedqvist P (1980) Modulation of neurotransmission by purine nucleotides and nucleosides. Biochemical Pharmacology 29:1635-1645.
    37. Ganio MS, Klau JF, Casa DJ, Armstrong LE, Maresh CM (2009) Effect of caffeine on sport- specific endurance perfonmance: a systematic review The Journal of Strength and Conditioning Research 23:315-24.
    38. Garrett BE, Holtzman SG (1994) D1 and D2 dopamine receptorantagonists block caffeine- induced stimulation of locomotor activity in rats. Pharmacology Biochemistry and Behavior 47:89-94.
    39. Gepdiremen A, Sönmez S, Ikbal M, Düzenli S, Tuna S (1998) Response to nimodipine in caffeine- induced neurotoxicity in cerebellar granular cell culture of rat pups. Pharmacological Research 38:239-242.
    40. Góngora-Alfaro JL, Moo-Puc RE, Villanueva TJ, Arankowsky-Sandoval G, Álvarez-Cervera FJ, Pineda-Cortés JC, Heredia-López FJ, Bata-García JL (2005) La cafeína y los antagonistas de los receptors A2A de la adenosina como posibles adyuvantes de la terapia anticolinérgica en la enfermedad del Parkinson. Revista Biomedica 16:99-111.
    41. Griffiths RR, Wooddsom PP (1988) Caffeine physical dependence: a review of human and laboratory animal studies. Journal of Psychopharmacology 94:437-451.
    42. Halldner L, Adén U, Dahlberg V, Johansson B, Ledent C, Fredholm BB (2004) The Adenosine A1 receptor contributes to the stimulatory, but not the inhibitory effect of caffeine on locomotion: a study in mice lacking adenosine A1 and/ or A2A receptors. Neuropharmacology 46:1008-1017.
    43. Hoexter MQ, Rosa PS, Tufik S, Mello LE (2005) Consequences of Prolonged Caffeine Administration and Its Withdrawal on Pilocarpine- and Kainate- induced Seizures in Rats. Epilepsia 46:1401-1406.
    44. Hohoff C, Mullings EL, Heatherley SV, Freltag CM, Neumann LC, Domschke K, Krakowitzky P, Rothermundt M, Keck ME, Erthardt A, Unschuld PG, Jacob C, Fritze J, Bandelow B, Maler W, Holsboer F, Rogers PJ, Deckert J (2010) Adenosine A(2A) receptor gene: evidence for association of risk variants with panic disorder and anxious personality. Journal of Psychiatic Research 44:930-937.
    45. Hughes RN, (2016) Neurobehavioral Aspects of Caffeine In: Preedy VR (ed) Neuropathology of Drug Addictions and Substance Misuse, Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non- Drug Addictions, (Academis Press), pp 775- 784.
    46. Ilback NG, Siller M, Stalhandske T (2007) Evaluation of cardiovascular effects of caffeine using telemetric monitoring in the conscious rat. Food and Chemical Toxicology 45:834-842.
    47. Isokawa M (2016) Caffeine-induced suppression of GABAergic inhibition and calcium-independent metaplasticity. Neural Plasticity doi:http://dx.doi.org/10.1155/2016/1239629.
    48. Johansson B, Halldner L, Dunwiddie TV, Masino SA, Poelchen W, Giménez- Llort L, Escorihuela RM, Fernández- Teruel A, Wiesenfeld- Hallin Z, Xu XJ, Hardemark A, Betsholtz C, Herlenius, E, Fredholm BB (2001) Hyperalgesia, Anxiety, and Dercreased Hypoxic Neuroprotection in Mice Lacking the Adenosine A1 Receptor. Proceedings of the National Academy of Sciences of the United States of America 98:9407-9412.
    49. John J, Kodama T, Siegel JM (2014) Caffeine promotes glutamate and histamine release in the posterior hypothalamus. American Journal of Physiology- Regulatory Integrative and Comparative Physiology 307:R704- R710.
    50. Kalda A, Yu L, Oztas E, Chen JF (2006) Novel Neuroprotection by Caffeine and Adenosine A(2A) Receptor Antagonists in Animal Models of Parkinson´s Diseases. Journal of the Neurological Science 248:9-15.
    51. Kamp TJ, Hell JW (2000) Regulation of cardiac L- type calcium channels by protein kinase A and protein kinase C. Circulation Research 87:1095-1102.
    52. Kang SH, Lee YA, Won SJ, Rhee KH, Gwag BJ (2002) Caffeine- induced Neuronal Death in Neonatal Rat Brain and Cortical Cell Cultures. Neuroreport 13:1945-1950.
    53. Kerkhofs A, Xavier AC, da Silva BS, Cans PM, Sander I, Johannes CB, Samira GF, Rodrigo AC, Huibert DM (2017) Caffeine Controls Glutamatergic Synaptic Transmission and Pyramidal Neuron Excitability in Human Neocortex. Frontiers in Pharmacology 8:899.
    54. Kim IY, O´Reilly EJ, Hughes KC, Gao X, Schwarzschild MA, McCullough ML, Hannan MT, Betensky RA, Ascherio A (2018) Interaction Between Caffeine and Polymorphisms of Glutamate Inotropic Receptor NMDA Type Subunit 2A (GRIN2A) and Cytochrome P450 1A2 (CYP1A2) on Parkinson´s Disease Risk. Movement Disorders 33:414-420.
    55. Kolahdouzan M, Hamadeh MJ (2016) The neuroprotective effects of caffeine in neurodegenerative diseases. CNS Neuroscience & Therapeutics 23:272-290.
    56. Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ, Costentin J, Heath JK, Vassart G, Parmentier M (1997) Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2A receptor. Nature 388:674-678.
    57. Lee CH, George O, Kimbrough A (2020) Chronic voluntary caffeine intake in male Wistar rats reveals individual differences in addiction- like behavior. Pharmacology, Biochemistry and Behavior 191:172880.
    58. Leite MR, Wilhelm EA, Jesse CR, Brandäo R, Nogueira CW (2011) Protective effect of caffeine and a selective A2A receptor antagonist on impairment of memory and oxidative stress of aged rats. Experimental Gerontology 46:309-15.
    59. Lopes JP, Pliássova A, Cunha RA (2019) The physiological effects of caffeine on synaptic transmission and plasticity in the mouse hippocampus selectively depend on adenosine A1 and A2A receptors. Biochemical Pharmacology 166:313-321.
    60. Lucas M, Mirzaei F, Pan A, Okereke OI, Willett W, O´Reilly EJ, Koenen K, Ascherio A (2011) Coffee, Caffeine, and risk of depression among women. Archives of Internal Medicine 171:1571-1578.
    61. Lv X, Chen Z, Li J, Zhang L, Liu H, Huang C, Zhu P (2010) Caffeine protects against alcoholic liver injury by attenuating inflammatory response and oxidative stress. Inflammation Research 59:635-645.
    62. Marchi M, Raiteri L, Risso F, Vallarino A, Bonfanti A, Monopoli A, Ongini E, Raiteri M (2002) Effect of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes. British Journal of Pharmacology 136:434-440.
    63. Marin MT, Zancheta R, Paro AH, Possi APM, Cruz FC, Planeta CS (2011) Comparison of caffeine- induced locomotor activity between adolecent and adult rats. European Journal of Pharmacology 660:363-367.
    64. Mc Lellan TM, Caldwell JA, Lieberman HR (2016) A Review of caffeine´s effects on cognitive, physical and occupational performance. Neuroscience & Biobehavioral Reviews 71:294-312.
    65. Mitchell DC, Knight CA, Hockenberry J, Teplansky R, Hartman TJ (2014) Beverage caffeine intakes in the U.S. Food and Chemical Toxicology 63:136-142.
    66. Mukhopadhyay S, Poddar MK (1998) Is GABA involved in the development of caffeine tolerance? Neurochemical Research 23:63-68.
    67. Nehlig A (1999) Are we dependent upon coffee and caffeine? A review on human and animal data. Neuroscience & Biobehavioral Reviews 23:563-576.
    68. Ohta A, Sitkovsky M (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414:916-920.
    69. Oztas E, Kalda A, Xu K, Irrizary MC, Schwarzchild MA, Chen JF (2002) Caffeine attenuates MPTP- induced loss dopaminergic neurons in substantia nigra in mice. Society for Neuroscience A487.6.
    70. Pan HZ, Chen HH (2007) Hyperalgesia, low- anxiety, and impairment of avoidance learning in neonatal caffeine- treated rats. Psychopharmacology (Berl) 191:119-125.
    71. Park PE, Schlosburg JE, Vendruscolo LF, Schulteis G, Edwards S, Koob GF (2015) Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence-induced hyperalgesia. Addiction Biology 20:275-284.
    72. Popoli P, Betto P, Reggio R, Ricciarello G (1995) Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats. European Journal of Pharmacology 287:215-7.
    73. Popoli P, Pintor A, Domenici MR (2002) Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid- induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum. Journal of Neuroscience 22:1967-1975.
    74. Price JL (2005) Free will versus survival: brain systems that underlie intrinsic constraints on behavior. The Journal of Comparative Neurology 493:132-139.
    75. Qian J, Chen Q, Ward SM, Duan E, Zhang Y (2019) Impacts of Caffeine during Pregnancy. Trends in Endocrinology & Metabolism 31:218-227.
    76. Ribeiro JA, Sebastiäo AM, de Mendonca A (2002) Adenosine receptors in the nervous system: pathophysiological implications. Progress in Neurobiology 68:377-392.
    77. Rosin DL, Robeva A, Woodard RL, Guyenet PG, Linden J (1998) Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system. The Journal of Comparative Neurology 401:163-86.
    78. Salamone JD, Correa M (2012) The mysterious motivational functions of mesolimbic dopamine. Neuron 76:470-485.
    79. Sebastiao AM, Ribeiro JA (1996) Adenosine A2 receptor- mediated excitatory actions on the nervous system. Progress in Neurobiology 48:167-189.
    80. Sheth S, Brito R, Mukherjea D, Rybak LP, Ramkumar V (2014) Adenosine receptors: expression, function and regulation. International Journal of Molecular Sciences 15:2024-2052.
    81. Shi D, Nikodijevic ́ O, Jacobson KA, Daly JW (1994) Effects of chronic caffeine on adenosine, dopamine and acetylcholine systems in mice. Archives Internationales de Pharmacodynamie et de Therapie 328:261.
    82. Simoes AP, Machado NJ, Goncalves N, Kaster MP, Simoes AT, Nunes A, Pereira de Almeida L, Goosens KA, Rial D, Cunha RA (2016) Adenosine A2A receptors in the amygdala control synaptic plasticity and contextual fear memory. Neuropsychopharmacology 41:2862-2871.
    83. Smith JE, Lawrence AD, Diukova A, Wise RG, Rogers PJ (2012) Strom in a coffe cup: caffeine modifies brain activation to social signals of treat. Social Cognitive and Affective Neuroscience 7:831-840.
    84. Soellner DE, Grandys T, Nuñez JL (2009) Chronic prenatal caffeine exposure impairs novel object recognition and radial arm maze behaviors in adult rats. Behavioral Brain Research 205:191-199.
    85. Sökmen B, Armstrong LE, Kraemer WJ, Casa DJ, Dias JC, Judelson DA, Maresh CM, (2008) Caffeine use in sports: cosniderations for the athlete. The Journal of Strength and Conditioning Research 22:978-986.
    86. Solinas M, Ferre S, Zhi-Bing Y, Karcz-Kubicha M, Popoli P, Steven RG (2002) Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens, Journal of Neurosciences 22:6321-6324.
    87. Southward K, Rutherfurd- Markwick K, Ali A (2018) The Effect of Acute Caffeine Ingestion on Endurance Performance: A Systematic Review and Meta- Analysis. Sport Medicine 48:1913-1928.
    88. Spaeth AM, Goel N, Dinges D (2014). The Cumulative Neurobehavioral and Physiological Effects of Chronic Caffeine Intake: Individual Differences and Implications for the Use of Caffeinated Energy Products Nutrition Reviews 72:34-47.
    89. Svenningsson P, Hall H, Sedvall G, Fredholm BB (1997) Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse 27:322-335.
    90. Van Koert RR, Bauer PR, Schuitema I, Sander JW, Visser GH (2018) Caffeine and seizures: A systematic review and quantitative analysis. Epilepsy & Behavior 80:37-47.
    91. Vesoulis ZA, McPherson C, Neil JJ, Mathur AM, Inder TE (2016) Early High- Dose Caffeine Increases Seizure Burden in Extremely Preterm Neonates: A Preliminary Study. Journal of Caffeine Research 6:101-107.
    92. Villanueva-García D (2007) Acute lung diseases. En: Ballesteros del Olmo JC, Villanueva-García D, Castro MJ, Cruz Castelazo MC, Delgadillo Avendaño JM, Estrada Flores JV. PAC Pediatría-V. Libro 11. Enfermedades pulmonares en el recién nacido. México: Intersistemas; pp. 690-695.
    93. Villanueva-García D (2011) Pulmonary Arterial Hypertension. En: Murguía T, Villanueva D, Lara G, editors. Neonatología, esencia, arte y praxis. Mc Graw Hill, Mexico City, Mexico, pp. 88-94.
    94. Villanueva-García D, Ibarra RD (2016) Chapter: Bronchopulmonary dysplasia. Programa de Actualización Continua en Neonatología, PAC®. Federación Nacional de Neonatología de México AC. En: Mancilla and Villanueva-García editors. Editado por Intersistemas S.A. de CV. Neonatologia-4/Libro 2/Insuficiencia Respiratoria Neonatal, Ciudad de México, pp. 40-58.
    95. Villegas SR, Villanueva-García D (2016) Transient tachypnea of the newborn. Programa de Actualización Continua en Neonatología, PAC®. Federación Nacional de Neonatología de México AC. En: Mancilla and Villanueva-García editors. Editado por Intersistemas S.A. de CV. Neonatologia-4/Libro 2/Insuficiencia Respiratoria Neonatal, Ciudad de México, pp. 40-58.
    96. Volkow ND, Wang GJ, Logan J, Alexoff D, Fowler JS, Thanos PK, Wong C, Casado V, Ferre S, Tomasi D (2015) Caffeine increases striatal dopamine D2/ D3 receptor availability in the human brain. Translational Psychiatry 5:e549.
    97. Watanabe H, Uramoto H (1986) Caffeine mimics dopamine receptor agonists without stimulation of dopamine receptors. Neuropharmacology 25:577-581.
    98. Yasuhara M, Levy G (1988) Caffeine as a potential risk factor for theophylline neurotoxicitym. Journal of Pharmaceutical Sciences 77:745-747.
    99. Zheng X, Hasegawa H (2016) Administration of Caffeine Inhibited Adenosine Receptor Agonist- Induced Decreases in Motor Performance, Thermoregulation, and Brain Neurotransmitter Release in Exercising Rats. Pharmacology, Biochemistry and Behavior 140:82-89.
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2020 Malque Publishing

How to cite

Villanueva-García, D., Mota-Rojas, D., Miranda-Cortés, A., Mora-Medina, P., Hernández-Avalos, I., Casas-Alvarado, A., Olmos-Hernández, A., & Martínez-Burnes, J. (2020). Neurobehavioral and neuroprotector effects of caffeine in animal models. Journal of Animal Behaviour and Biometeorology, 8(4), 298–307. https://doi.org/10.31893/jabb.20039
Crossref
Scopus
Google Scholar
Europe PMC
  • Article viewed - 200
  • PDF downloaded - 98